View Agent
| Agent Info | |
| Agent: | RAF265 |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | Melanoma …(phase II) |
| Classification: | an oral small molecule inhibitor of mutant (mut) BRAF V600E(EC50= 0.14µM) and VEGFR2 (EC50 = 0.19µM). |
| Target: | mRNA of RAF proto-oncogene serine/threonine-protein kinase |
| KEGG Pathway: | NA |
| Wiki Pathway: | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling Regulation of Actin Cytoskeleton IL-2 Signaling Pathway TGF beta Signaling Pathway Signaling of Hepatocyte Growth Factor Receptor AGE/RAGE pathway TNF alpha Signaling Pathway B Cell Receptor Signaling Pathway TtheyAK Signaling Pathway Leptin signaling pathway TCR Signaling Pathway EGF/EGFR Signaling Pathway IL-3 Signaling Pathway Iron uptake and transport Signaling Pathways in Glioblastoma Senescence and Autophagy in Cancer EPO Receptor Signaling Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell Oncostatin M Signaling Pathway FSH signaling pathway MAPK Cascade Extracellular vesicle-mediated signaling in recipient cells RAF/MAP kinase cascade Integrated Pancreatic Cancer Pathway Rap1 signalling MAPK Signaling Pathway PDGF Pathway Endothelin Pathways MicroRNAs in cardiomyocyte hypertrophy Cardiac Hypertrophic Response Interleukin-11 Signaling Pathway Integrin-mediated Cell Adhesion GP1b-IX-V activation signalling Insulin Signaling Kit receptor signaling pathway Nanoparticle-mediated activation of receptor signaling Retinoblastoma (RB) in Cancer BDNF signaling pathway Corticotropin-releasing hormone Prostate Cancer IL-5 Signaling Pathway |